- SenesTech, a rodent fertility control product and service provider, just launched Evolve(TM) Mouse, a contraceptive specifically designed for mice
- This marks an extension of the company’s hugely successful Evolve product line, ushering its official entry into the mouse contraceptive market
- SenesTech looks to replicate the positive results achieved in rats while tapping into a vastly growing market that currently accounts for over $1 billion in sales annually
- The company began taking orders for the product on May 6, with shipment set to begin on or before May 15
SenesTech (NASDAQ: SNES), a rodent fertility control product provider and the inventor of the only EPA-registered contraceptive for male and female rats, is pleased to announce the launch of its Evolve(TM) Mouse product, the company’s official entry into the mouse contraceptive market. This marks an extension of the company’s Evolve fertility product line, with its proven efficacy in reducing rat populations. Evolve was only launched in January 2024 and has already seen rapid and growing adoption in the field, including its application in controlling the highly publicized rat problem in New York City.
“We’re not just offering a product; we’re offering a solution to a growing crisis,” noted Joel Fruendt, SenesTech’s President and CEO. “Evolve Mouse isn’t just about control – it’s about reclaiming our spaces from the relentless invasion of…
NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com
InvestorWire is powered by IBN
